Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
3,148,458
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
277
-
Shares change
-
-139
-
Total reported value, excl. options
-
$1,226
-
Value change
-
+$10
-
Number of buys
-
2
-
Number of sells
-
1
-
Price
-
$4.40
Institutional Holders of GT Biopharma, Inc. - Common Stock (GTBP) as of Q1 2024
4 filings reported holding GTBP - GT Biopharma, Inc. - Common Stock as of 31 Mar 2024.
GT Biopharma, Inc. - Common Stock (GTBP) had 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 277 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC, JPMORGAN CHASE & CO, Advisory Services Network, LLC, VANGUARD GROUP INC, BANK OF MONTREAL /CAN/, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., WELLS FARGO & COMPANY/MN, and Tower Research Capital LLC (TRC).
This table shows the top 3 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.